Nextwellness USA LLC – Trademark Portfolio
Entity Type: 16
Nextwellness USA LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CONTOURSKIN and NEXT WELLNESS. The owner is based in Miami, FL.
1100 Brickell Bay Dr. #310747
Miami, FL 33231
Showing of trademarks Trademarks
Trademark Classifications
Nextwellness USA LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Nextwellness USA LLC have?
Nextwellness USA LLC has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.
What trademark classes does Nextwellness USA LLC file in?
Nextwellness USA LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Nextwellness USA LLC's most well-known trademarks?
Nextwellness USA LLC's registered trademark portfolio includes well-known marks such as CONTOURSKIN and NEXT WELLNESS. These are among 2 currently registered trademarks in the portfolio.
What is Nextwellness USA LLC's trademark registration success rate?
Nextwellness USA LLC has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.